Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Some babies are born with alopecia areata, and a treatment with clobetasol propionate can regrow hair in half of the cases.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Gastric exclusion surgery caused major weight loss and health improvements but led to some anemia and vitamin deficiencies.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Using microneedles before applying eflornithine cream can make it more effective at stopping hair growth.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.